Prenetics Global Limited (NASDAQ:PRE) Short Interest Update

Prenetics Global Limited (NASDAQ:PRE) was the target of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 32,600 shares, a drop of 24.7% from the January 15th total of 43,300 shares. Approximately 0.4% of the shares of the company are sold short. Based on an average daily volume of 14,000 shares, the days-to-cover ratio is currently 2.3 days.

Wall Street Analyst Weigh In

Separately, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $9.00 price objective on shares of Prenetics Global in a research note on Thursday, January 16th.

Prenetics Global Price Performance

Prenetics Global stock traded down $0.07 during trading on Friday, reaching $5.44. The company had a trading volume of 1,295 shares, compared to its average volume of 20,145. The firm’s 50-day simple moving average is $5.57 and its 200 day simple moving average is $5.03. Prenetics Global has a 1-year low of $2.85 and a 1-year high of $7.84.

Prenetics Global (NASDAQ:PRE) last released its quarterly earnings results on Wednesday, November 27th. The company reported ($0.84) earnings per share (EPS) for the quarter. Prenetics Global had a negative net margin of 191.73% and a negative return on equity of 16.45%. As a group, equities research analysts anticipate that Prenetics Global will post -3.3 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Prenetics Global

An institutional investor recently bought a new position in Prenetics Global stock. Quinn Opportunity Partners LLC bought a new position in shares of Prenetics Global Limited (NASDAQ:PRE) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 12,339 shares of the company’s stock, valued at approximately $72,000. Quinn Opportunity Partners LLC owned about 0.10% of Prenetics Global as of its most recent SEC filing. 25.01% of the stock is owned by institutional investors.

Prenetics Global Company Profile

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.